To summarize, high CALCRL expression was associated with stemness, relapse, and poor outcome of AML, and higher expression of CALCRL in LSCs versus HSCs suggests the existence of a potential therapeutic window for CALCRL inhibitors. Here, CALCRL is linked to acute myeloid leukemia.